Ozempic and Wegovy, used for diabetes and weight loss, are now linked to a rare eye condition called NAION, or "eye stroke." ...

Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.

Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

A nomogram using ocular hemodynamics and clinical factors accurately predicts ischemic stroke risk, offering a novel tool for ...

No single food can reduce the risk of stroke; rather, eating a diet plentiful in fruits, vegetables, legumes, nuts, seeds, ...

When treating an ischemic stroke – where a clot is blocking the flow of oxygen to the brain – every minute counts.

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...

In 2021, the number of people affected by stroke worldwide exceeded 93.8 million, with over 7.25 million related deaths.